Classifies medetomidine as a Schedule III controlled substance in South Dakota, with exceptions for veterinary uses.

South Dakota HB1169 classifies any material containing medetomidine as a Schedule III controlled substance, effective January 1, 2026. Exceptions include veterinary uses approved by the U.S. Secretary of Health and Human Services, manufacturing and distribution for animal drugs, and use as an active pharmaceutical ingredient or bulk chemical for compounding by licensed pharmacists or veterinarians.

Classifies medetomidine as a Schedule III controlled substance in South Dakota, with exceptions for veterinary uses.

South Dakota HB1169 classifies any material containing medetomidine as a Schedule III controlled substance, effective January 1, 2026. Exceptions include veterinary uses approved by the U.S. Secretary of Health and Human Services, manufacturing and distribution for animal drugs, and use as an active pharmaceutical ingredient or bulk chemical for compounding by licensed pharmacists or veterinarians.